CINECA IRIS Institutional Research Information System

BALDOVINO, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.306
EU - Europa 6.200
AS - Asia 5.101
SA - Sud America 1.304
AF - Africa 182
OC - Oceania 106
Continente sconosciuto - Info sul continente non disponibili 23
Totale 22.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.722
IT - Italia 1.973
CN - Cina 1.698
SG - Singapore 1.300
DE - Germania 649
BR - Brasile 646
FR - Francia 505
ES - Italia 430
JP - Giappone 428
IE - Irlanda 409
GB - Regno Unito 375
MX - Messico 351
SE - Svezia 307
VN - Vietnam 291
FI - Finlandia 272
IN - India 256
KR - Corea 229
CO - Colombia 222
UA - Ucraina 213
CA - Canada 180
TR - Turchia 158
PL - Polonia 146
AR - Argentina 145
ID - Indonesia 144
AT - Austria 123
RU - Federazione Russa 109
HK - Hong Kong 104
NL - Olanda 103
GR - Grecia 95
AU - Australia 94
CH - Svizzera 85
CL - Cile 80
PT - Portogallo 80
TW - Taiwan 77
PE - Perù 68
SA - Arabia Saudita 67
EC - Ecuador 63
RO - Romania 57
BE - Belgio 55
TH - Thailandia 52
IR - Iran 51
IL - Israele 47
EG - Egitto 42
VE - Venezuela 39
PK - Pakistan 29
SI - Slovenia 29
CZ - Repubblica Ceca 26
RS - Serbia 26
ZA - Sudafrica 26
DZ - Algeria 22
NO - Norvegia 22
EU - Europa 21
PH - Filippine 21
TN - Tunisia 20
DK - Danimarca 19
AE - Emirati Arabi Uniti 18
BD - Bangladesh 17
IQ - Iraq 17
UZ - Uzbekistan 17
PS - Palestinian Territory 16
UY - Uruguay 16
HU - Ungheria 15
MA - Marocco 15
LT - Lituania 14
MY - Malesia 14
PY - Paraguay 14
BG - Bulgaria 13
NG - Nigeria 13
HR - Croazia 12
NZ - Nuova Zelanda 12
BO - Bolivia 10
CR - Costa Rica 10
GT - Guatemala 9
JO - Giordania 8
NI - Nicaragua 8
AZ - Azerbaigian 7
KE - Kenya 7
LB - Libano 7
BY - Bielorussia 6
LK - Sri Lanka 6
PA - Panama 6
QA - Qatar 6
SK - Slovacchia (Repubblica Slovacca) 6
CI - Costa d'Avorio 5
EE - Estonia 5
NP - Nepal 5
CM - Camerun 4
DO - Repubblica Dominicana 4
GH - Ghana 4
MK - Macedonia 4
MT - Malta 4
RE - Reunion 4
BF - Burkina Faso 3
BS - Bahamas 3
CU - Cuba 3
LI - Liechtenstein 3
SV - El Salvador 3
UG - Uganda 3
AN - Antille olandesi 2
BN - Brunei Darussalam 2
Totale 22.181
Salva come PNG Salva come JPEG
Città #
Ann Arbor 902
Beijing 663
Singapore 654
Santa Clara 627
Chandler 543
Fairfield 501
Dublin 389
Redwood City 380
Houston 364
Torino 361
Ashburn 350
Wilmington 333
Woodbridge 240
Seattle 214
Villeurbanne 173
Cambridge 161
Turin 158
Jacksonville 148
Munich 141
Medford 136
Princeton 132
Milan 128
Pisa 121
Columbus 109
Dearborn 108
Tokyo 105
Warsaw 104
Nyköping 101
Los Angeles 100
Guangzhou 97
Shanghai 95
Helsinki 86
Buffalo 84
Lubbock 83
São Paulo 81
Vienna 80
Bogotá 77
Dong Ket 77
Jakarta 70
Madrid 68
Seoul 68
Rome 67
Dallas 66
Fremont 66
Nanjing 65
Hong Kong 63
Ho Chi Minh City 62
Boston 60
Hangzhou 59
New York 58
Santiago 56
Barcelona 52
Hanoi 51
Medellín 51
San Diego 49
London 44
Mexico City 44
Buenos Aires 43
Hefei 42
Paris 42
Lima 41
Chengdu 38
Toronto 38
Istanbul 37
Chicago 36
Taipei 36
Mumbai 31
Guadalajara 30
Osaka 30
Belo Horizonte 29
Silver Spring 29
Athens 28
Boardman 27
Quito 26
Wuhan 26
Düsseldorf 25
Nuremberg 25
Ankara 24
Changsha 24
Mexico 24
Zapopan 24
Zhengzhou 24
Ottawa 23
Sesto San Giovanni 23
Brussels 22
Cuauhtémoc 22
Lisbon 22
Norwalk 22
Padova 22
Rio de Janeiro 22
Jinan 21
Frankfurt am Main 20
Montreal 20
Redondo Beach 20
Turku 20
Phoenix 19
Gurgaon 18
Lissone 18
New Delhi 18
Riyadh 18
Totale 11.474
Salva come PNG Salva come JPEG
Nome #
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.137
Acute kidney injury associated with glomerular diseases 1.132
Antiphospholipid Syndrome and the Kidney 944
Value of colchicine as treatment for recurrent oral ulcers: a systematic review 688
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 629
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 583
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 576
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 568
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 551
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 521
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 501
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 474
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 454
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 432
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 373
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 366
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 335
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 323
Upcoming biological therapies in systemic lupus erythematosus. 311
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 308
Long-term evaluation of pemphigus vulgaris: a retrospective consideration of 98 patients treated in an oral medicine unit in North-West Italy 306
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 274
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 257
Rituximab in cryoglobulinemic peripheral neuropathy 250
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 249
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 234
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 233
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 218
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 215
The prompt use of rituximab could decrease adverse effects in patient with pemphigus vulgaris: a preliminary evaluation 212
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 211
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 207
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 205
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab 198
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 196
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 186
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 185
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 173
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond 168
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience 168
Filling the gap in antiphospholipid syndrome diagnosis: a patient's story 164
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris 158
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 150
Extemporaneous orphan drugs and preparations for rare diseases: organisation and management of an inter-regional network 144
External Quality Assurance (EQA) of Immunofixation and serum free light chain measure in 9 laboratories participating in the Piedmont and Aosta Valley consortium for systemic amyloidosis 144
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis 144
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 143
First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy 141
Short and long-term effects of Rituximab in the treatment of severe cryoglobulinaemia with and without glomerulonephritis 140
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy 134
Analisi di Copy-Number Variants (CNV) e dei polimorfismi del gene C4 nelle vasculiti primitive e secondarie e nell’ artrite reumatoide. 132
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 129
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 126
null 122
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 120
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso Sistemico 117
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 117
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature 116
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 115
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 113
Anticorpo monoclonale anti CD20 nella crioglobulinemia mista 111
Effetti a lungo termine del rituximab nel trattamento delle forme più severe di crioglobulinemia mista HCV associata 111
Immunological rare diseases 110
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 108
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 102
Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North Western Italy cohort 101
Cryoglobulinemic glomerulonephritis: Clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy 100
Association between hereditary angioedema and lupus erythematosus in the mother and the son 98
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature 96
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis 96
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia 91
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso sistemico 90
Induction of remission by B lymphocyte depletion in patients with idiopathic systemic vasculitis 90
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 89
Percorso gestionale standardizzato dalla prescrizione all'erogazione di galenici magistrali per pazienti affetti da malattie rare ed allestiti presso le farmacie ospedaliere di Piemonte e Valle d'Aosta 89
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease 89
Short and long term effects on Rituximab in the treatment of severe cryoglubulinaemia with and without glomerulonephritis 88
EFFECTS OF RITUXIMAB IN THE TREATMENT OF SEVERE CRYOGLOBULINAEMIA 85
INTENSIFIED B LYMPHOCYTE DEPLETION (IBLD) WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE TREATMENT AS A RESCUE THERAPY IN REFRACTORY LUPUS NEPHRITIS (LN): A 4-YEAR OBSERVATION 85
Alterazioni videocapillaroscopiche nella crioglobulinemia mista ocn danno renale 84
Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases. 83
Immunogenetics of complement in mixed cryoglobulinaemia 81
La crioglobulinemia mista 79
Induction of remission by B lynfocyte depletion in patients with idiopathic systemic vasculitis 79
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies 79
Piedmont and Aosta Valley Consortium of Systemic Amyloidosis: results of a four year experience 78
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App 77
Improving diagnosis for rare diseases: The experience of the Italian undiagnosed Rare diseases network 77
Nail fold capillaroscopy in mixed cryoglobulinaemia 74
Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation 74
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience 72
Rare diseases in Europe: From a wide to a local perspective 72
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 72
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia 71
Structural and functional properties of proteasomes purified from the human kidney 70
Orofacial granulomatosis as an uncommon presentation of common variable immunodeficiency (CVID) 70
Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease 70
Malattie Rare: la rete di segnalazione 69
Minocycline in combination with mycophenolate mofetil in oral mucous membrane pemphigoid 69
Relationship between cryoglobulinemia-associated nephritis and HCV infection 68
Totale 21.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.119
article - articoli 0
book - libri 0
conference - conferenze 9.476
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.737 0 0 0 0 245 197 162 173 214 239 220 287
2021/20223.033 153 163 201 295 321 286 326 273 221 178 277 339
2022/20232.496 252 194 89 175 177 524 205 221 257 113 165 124
2023/20241.791 230 224 141 134 178 132 127 114 41 134 132 204
2024/20253.657 88 206 211 309 815 291 201 239 402 223 258 414
2025/20261.966 429 269 360 621 287 0 0 0 0 0 0 0
Totale 22.847